Login / Signup

Myopathy and scleromyxedema.

Antoine SoulagesHoang Marie-Ange TangAnne Pham-LedardMarie-Laure Négrier-LeibreichAlexandre CosnardFanny DuvalGuilhem SoléLouis CarlaGwendal Le MassonStéphane Mathis
Published in: Journal of neurology (2019)
Scleromyxedema is a chronic, idiopathic disorder associated with monoclonal gammopathy, and characterized by dermal mucin deposition. However, systemic manifestations are frequent, including neuromuscular symptoms. We herein present a 71-year-old man who developed a vacuolar myopathy in a context of a known scleromyxedema, and we compare our observation with the nineteen other cases found in the medical literature. Such an association (especially with suggestive skin abnormalities) has to be known for two reasons. First, this diagnosis might be quite challenging because the myopathy may precede the typical skin changes. Secondly, conversely to other forms of vacuolar myopathy, some of the symptoms may respond (even partially) to immunomodulatory and/or immunosuppressant therapeutics.
Keyphrases
  • late onset
  • muscular dystrophy
  • wound healing
  • soft tissue
  • early onset
  • systematic review
  • healthcare
  • sleep quality
  • physical activity
  • multiple myeloma
  • drug induced
  • depressive symptoms